- Home
- GTBP vs ADXN Comparison
GTBP vs ADXN Comparison
Compare GTBP & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- ADXN
- Stock Information
- Founded
- GTBP 1965
- ADXN 2002
- Country
- GTBP United States
- ADXN Switzerland
- Employees
- GTBP N/A
- ADXN N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- GTBP Health Care
- ADXN Health Care
- Exchange
- GTBP Nasdaq
- ADXN Nasdaq
- Market Cap
- GTBP 6.8M
- ADXN 8.0M
- IPO Year
- GTBP N/A
- ADXN N/A
- Fundamental
- Price
- GTBP $2.39
- ADXN $7.97
- Analyst Decision
- GTBP Strong Buy
- ADXN Strong Buy
- Analyst Count
- GTBP 1
- ADXN 1
- Target Price
- GTBP $11.00
- ADXN $30.00
- AVG Volume (30 Days)
- GTBP 1.3M
- ADXN 25.1K
- Earning Date
- GTBP 11-14-2024
- ADXN 11-22-2024
- Dividend Yield
- GTBP N/A
- ADXN N/A
- EPS Growth
- GTBP N/A
- ADXN N/A
- EPS
- GTBP N/A
- ADXN 0.06
- Revenue
- GTBP N/A
- ADXN $701,260.00
- Revenue This Year
- GTBP N/A
- ADXN N/A
- Revenue Next Year
- GTBP N/A
- ADXN N/A
- P/E Ratio
- GTBP N/A
- ADXN $1.03
- Revenue Growth
- GTBP N/A
- ADXN N/A
- 52 Week Low
- GTBP $1.72
- ADXN $6.45
- 52 Week High
- GTBP $10.66
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- GTBP 42.95
- ADXN 50.40
- Support Level
- GTBP $2.32
- ADXN $7.28
- Resistance Level
- GTBP $2.63
- ADXN $8.36
- Average True Range (ATR)
- GTBP 0.27
- ADXN 0.74
- MACD
- GTBP -0.05
- ADXN 0.05
- Stochastic Oscillator
- GTBP 33.00
- ADXN 50.26
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.